Contents
Current Topics in Medicinal Chemistry, Volume 15 - Number 10
Editorial
Dopamine D3 Agonists in the Treatment of Parkinson's Disease
, 15(10): 908 - 926Banibrata Das, Gyan Modi and Aloke Dutta
DOI: 10.2174/156802661510150328223428
Dopamine D3 Agonists in the Treatment of Parkinson's Disease
Inhibitors of Leucine-Rich Repeat Kinase 2 (LRRK2): Progress and Promise for the Treatment of Parkinson’s Disease
, 15(10): 927 - 938Paul J. Gilligan
DOI: 10.2174/156802661510150328223655
Inhibitors of Leucine-Rich Repeat Kinase 2 (LRRK2): Progress and Promise for the Treatment of Parkinson’s Disease
Design and Development of a Novel Supportive Care Product for the Treatment of Sialorrhea in Parkinson’s Disease
, 15(10): 939 - 954Neal M. Farber, Santiago Perez-Lloret and Elkan R. Gamzu
DOI: 10.2174/156802661510150328224130
Design and Development of a Novel Supportive Care Product for the Treatment of Sialorrhea in Parkinson’s Disease
Agonists of the Tissue-Protective Erythropoietin Receptor in the Treatment of Parkinson’s Disease
, 15(10): 955 - 969Juha Punnonen, James L. Miller, Timothy J. Collier and Jeffrey R. Spencer
DOI: 10.2174/156802661510150328224527
Agonists of the Tissue-Protective Erythropoietin Receptor in the Treatment of Parkinson’s Disease
Webmaster Contact: info@benthamscience.net